The largest database of trusted experimental protocols

First strand cdna synthesis kit

Manufactured by Cytiva
Sourced in United States, United Kingdom, Germany, Canada, Sweden

The First-strand cDNA synthesis kit is a laboratory product that enables the conversion of RNA into complementary DNA (cDNA). This kit provides the necessary reagents and protocols to perform this fundamental step in various molecular biology applications, such as gene expression analysis and reverse transcription-PCR.

Automatically generated - may contain errors

39 protocols using first strand cdna synthesis kit

1

Characterization of Oca2 Gene Mutations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Messenger RNA (mRNA) was extracted from the dorsal skin of mice at 12 weeks of age using
the QuickPrep Micro mRNA Purification Kit (Amersham Biosciences, Buckinghamshire,
England). First-strand complementary DNA (cDNA) was synthesized using a First-Strand cDNA
Synthesis Kit (Amersham Biosciences). A cDNA fragment for the Oca2 gene
was then amplified by PCR using 2 sets of primers (Table 1). These primers were designed based on the reported sequence for the
mouse Oca2 (NM_021879). The primer set 1 could amplify a region that
contains the nonsense substitution in NCT. The primer set 2 was designed to amplify a
downstream region of the nonsense substitution. PCR amplification was performed using
TaKaRa LA Taq DNA polymerase in 25 µl reactions
according to the manufacturer’s instructions. PCR reactions were carried out using the
following conditions: initial denaturation at 94°C for 1 min, followed by 40 cycles at
94°C for 20 s, 55°C for 15 s, and 72°C for 1 min. A 10 µl aliquot of each
PCR product was subjected to agarose gel electrophoresis. The PCR products were purified
and directly sequenced with the primers.
+ Open protocol
+ Expand
2

Quantitative RT-PCR Analysis of Cytokine Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The total RNA was isolated from the skin tissues using RNAzol B based on phenol–chloroform phase separation (RNAzol B: Tel-Test Co. Inc., Friendswood, TX, USA). The total RNA was isolated from the HaCaT cells using an RNeasy Mini Kit (Qiagen, Hilden, Germany). The total RNA (5 μg) was reverse-transcribed into cDNA using a first-strand cDNA synthesis kit (Amersham Pharmacia, Piscataway, NJ, USA). The mRNA was amplified using a TaqMan Universal Master Mix II (Applied Biosystems, Foster City, CA, USA) on an ABI 7500 RT-PCR instrument (Applied Biosystems). The qRT-PCR conditions consisted of an incubation step (2 min at 50 °C and 10 min at 94 °C) and an amplification step (40 cycles of 1 min each at 94 °C and 1 min at 60 °C). The relative mRNA expression of the target gene was calculated using the ΔΔCt method. The PCR primer sequences (IL-13, IL-31 receptor, IL-6, chemokine–chemokine receptor 3, TNF-α, and glyceralde-hyde-3-phosphate dehydrogenase) were used in the same way as in a previous study [25 (link)].
+ Open protocol
+ Expand
3

Quantifying Gene Expression in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from cell lines with TRIzol (Invitrogen) and cDNA was prepared from 2 mg of RNA using a First-Strand cDNA Synthesis Kit according to the manufacturer’s instructions (Amersham Biosciences, Amersham, UK). Oligonucleotide sequences were as follows: SHP-1, 5′-GCC CAG TTC ATT GAA ACC AC- 3′ (sense) and 5′-GAGGGAACCCTTGCTCTTCT-3′ (antisense); GAPDH, 5′-CGACCACTTTGTCAAGCTCA-3′(sense) and 5′-AGGGGTCTACATGGCAAC TG-3′ (antisense); RFX-1: 5′-CGGCAAGCACCAGCTACTAC-3′ (sense) and 5′-GGACACGTACATGGGCATGG-3′ (antisense). For QPCR, thermocycling was performed in a final volume of 20 μl containing 2.5 μl of cDNA sample, 200 nM of each of the primers, and 6.5 μl of SYBR Green I Master Mix (Roche) with Roche LightCycler 480 sequence detection system (RocheApplued Science, Foster, California). The following PCR conditions were used: denaturation at 95 °C for 10 min followed by 35 cycles of 94 °C for 1 min, annealing for 1 min at 57 °C, and elongation for 1 min at 72 °C, and a final elongation step at 72 °C for 10 min. Expression levels of genes of interest were normalized to that of GAPDH in the same sample.
+ Open protocol
+ Expand
4

RT-PCR Analysis of Ataxin-2 Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA from untransfected HeLa and HEK293 cells, human skin fibroblast and mouse brain or cerebellum was isolated using TRIZOL Reagent method (Invitrogen). The generation of cDNA from 5 μg RNA template was carried out with First-Strand cDNA Synthesis Kit (Amersham Bioscience). Human cDNA from cortex, cerebellum and liver were purchased from ClonTech Laboratories, Inc. 0ne μl of the first-strand mixture was added to 50 μl of the PCR mix containing 200 μM of dNTPs and 10 μM of sense and antisense primers (see Table 1). Amplified products were resolved on a 2% agarose-gel, purified using a QIAquick Gel Extraction kit (QIAGEN) and subjected to fluorescent DNA sequencing. All analyses were done at least in duplicate and reproduced.

Sequence of the primers used to perform the PCR for the different fragments of ataxin-2 and GAPDH as loading control

RT-PCRPrimer nameSequence 5’to 3´Length (bp)
AA-ForwardTGGGCAGAGGTCGAAACAGTAACA24
A-ReverseTGCATCCCAGGGCTCCAGGTC21
BB-ForwardAATGTTCAGACTTTGTTGTGGTA23
B-ReverseTCGGGTTGAAATCTGAAGTGTGAG24
CC-ForwardTGAGGGGCACAGCATAAACACT22
C-ReverseCGTAGGAGATGCAGCTGGAATAGG24
DD-ForwardGGGGGAACGTGGTCATCAGTGGT23
D-ReverseGGTTGCACGCCTGGGCTC18
EE-ForwardTCAGCCAAAGCCTTCTACTACCC23
E-ReverseCATGTTGGCTTTGCTGCTGTC21
FF-ForwardCCCAAATTACCATACAACAAGGAG24
F-ReverseGATGTGTTCATGACTTTCAAGG22
GAPDHForwardTTCACCACCATGGAGAAGGC20
ReverseGGCATCGACTGTGGTCATGA20
+ Open protocol
+ Expand
5

Aortic RNA Extraction and Real-Time PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA extraction and real-time PCR was performed as previously described [2 (link)]. Briefly, total aortic RNA was isolated using the TriPure Isolation Reagent (Roche) followed by purification with the RNeasy mini kit (Qiagen). CDNA was synthesized using the First Strand cDNA Synthesis kit (Amersham) and used for the 40-cycle 2-step PCR with sequence-specific primer pairs in the iCycler IQ Real-Time Detection System (Bio-Rad).
+ Open protocol
+ Expand
6

Gene Expression Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted with a QIAGEN RNeasy Plus Mini kit, and reverse transcription was completed with Superscript III (Life Technologies) treated with RNase-free DNase I and a first-strand cDNA synthesis kit (Amersham Biosciences) according to each manufacturer’s protocol. Synthesized cDNA was amplified with gene-specific primers. PCR products were separated by electrophoresis on a 2% agarose gel and detected under UV illumination.
+ Open protocol
+ Expand
7

Quantitative Assessment of APA Isoforms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from 20 glomeruli of each biopsy sample (Six control and six DN) using RNAeasy mini kit (Cat#74,004, QIAGEN Science, Germantown, MD) according to the manufacturer’s instruction. The cDNA was synthesized with the first-strand cDNA synthesis kit (Amersham, Buckmgahamshire, UK) and PCR was performed using the Geneamp PCR system (Sigma). The primers for the two isoforms of each gene with different 3′UTR lengths (CYB5R1-L, CYB5R1-S and PDLIM1-L, PDLIM1-S) were listed in Additional file 3: Table S2. The short primer was common to total APA isoforms (S + L) and the long primer was specific to the longer isoform (L). The relative expression of the two isoforms was quantified by qRT-PCR with GAPDH as internal reference.
+ Open protocol
+ Expand
8

Quantifying KIFC1 Expression in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from frozen cancer cell lines using Isogen (Nippon Gene, Tokyo, Japan), and 1 μg of total RNA was converted to cDNA with a first-strand cDNA synthesis kit (Amersham Biosciences Corp., Piscataway, NJ, USA). The qPCR was performed with a SYBR Select Master Mix (Applied Biosystems, Austin, TX, USA) as described previously [20 (link)]. ACTB-specific PCR products, which were amplified from the same RNA samples, served as internal controls. KIFC1 primer sequence: forward primer GACGCCCTGCTTCATCTG; reverse primer CCAGGTCCACAAGACTGAGG.
+ Open protocol
+ Expand
9

Quantifying Gene Expression by qRT-PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytoplasmic RNA was isolated using TRIzol (Invitrogen, ON, Canada) according to the manufacturer's instructions. RNA (0.5 µg) was reverse transcribed (RT) to cDNA from random hexamers using the first-strand cDNA synthesis kit from Amersham Biosciences (PA, USA). Quantitative RT-PCR (RT-qPCR) was performed using primers shown in Table S1. Primers were validated using a 5-point, 5-fold dilution series. The absence of non-specific amplification was confirmed by observing a single peak in the melt-curve analysis, confirmation of the expected amplicon size by agarose gel analysis and the absence of amplification in the no template control. qPCR was then performed in triplicate on the StepOne Plus (Applied Biosystems CA, USA) using Power SYBR Green PCR Master Mix (Applied Biosystems CA, USA). Cycling conditions were: 95 ºC for 10 min, 40 cycles at 95 ºC for 15 s and 60 ºC for 1 min followed by melt-curve analysis.
+ Open protocol
+ Expand
10

RNA Extraction and cDNA Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from tissues using TRIzol reagent (Invitrogen, Carlsbad, CA, USA), as described previously [18 (link)], and cDNA was synthesized from 1 µg of total RNA using the first strand cDNA synthesis kit (Amersham Biosciences Europe GmbH, Freiburg, Germany), according to the manufacturer's protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!